Navigation Links
NuRx Pharmaceuticals Announces Change of Ticker Symbol to NUXP, Reverse Stock Split Now in Effect
Date:5/12/2008

IRVINE, Calif., May 12 /PRNewswire-FirstCall/ -- NuRx Pharmaceuticals, Inc. (OTC Bulletin Board: NURX pre split, NUXP post split) today announced that on May 9th, the Company's 1-for-4 reverse stock split became effective. The Company has been informed by the Over The Counter Bulletin Board's Corporate Actions group that, in connection with the reverse stock split, its trading symbol has changed from NURX to NUXP.

The reverse stock split will reduce the number of issued and outstanding shares of NuRx's common stock from approximately 129.5 million shares (on a fully diluted basis) to approximately 34.3 million shares.

NuRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of next-generation retinoid and rexinoid compounds for application in oncology (treatment, prevention and adjunctive supportive therapy) and other highly prevalent diseases. The company's lead compounds are NRX5183, an RAR agonist for the treatment of acute leukemia, and NRX4204, a highly specific, next-generation rexinoid agonist that is targeted for development in non-small cell lung carcinoma and breast cancer. Based in Irvine, Calif., NuRx has a technology and IP platform that includes a library of nearly 6,000 compounds supported by 230 issued U.S. and international patents and more than 80 additional patents in application. For more information, visit http://www.nurxpharmaceuticals.com.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this news release, all forward-looking statements are predictions by the Company's management and are subject to various ri
'/>"/>

SOURCE NuRx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amylin Pharmaceuticals to Present at Baird Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
3. Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
4. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
5. Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
7. Onyx Pharmaceuticals to Present at Bank of America Health Care Conference
8. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
9. VIA Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
10. Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday, May 14, 2008
11. Arena Pharmaceuticals Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... The global companion diagnostics market ... It is expected to grow at a CAGR ... valued at $1.8 billion in 2013, according to ... , For more information regarding analysis details and ... research report, titled “Companion Diagnostics Market (Breast Cancer, ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Pittcon is ... MacDonald, and colleague Koichiro Matsuda, Horiba Scientific, have organized ... September 5, 2014. JASIS , Asia’s largest analytical ... 2014, in Makuhari Messe, Japan. , The four ... for Bioanalysis from Single Molecules to Single Cells” will ...
(Date:8/29/2014)... 29, 2014 Local veterinarian, Dr. Keith ... are seeking candidates to participate in an investigational study ... The ultimate goal of this study is to determine ... one or two arthritically affected joints can help reduce ... Candidates for the current investigational study must be older ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Due to a ... last week, the Adult Stem Cell Technology Center, LLC ( ... support stem cell therapy research that might benefit ALS patients. ... cells for new stem cell technologies and therapeutic applications, FRC ... Ice Bucket Challenge donors who wish not to support ...
Breaking Biology Technology:Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3
... on RDEA119 at the 2007, AACR-NCI-EORTC Conference ... SAN FRANCISCO, Oct. 24 Ardea Biosciences,Inc. (Nasdaq: ... discovery and development of,small-molecule therapeutics for the treatment ... preclinical data on its lead MEK,inhibitor, RDEA119, at ...
... 24 The Interstate,Alliance for Stem Cell Research should ... future sessions, the Foundation for Taxpayer and,Consumer Rights (FTCR) ... of various state,stem cell programs, is meeting today and ... Alliance is still in its early stages, it is ...
... Emisphere,Technologies, Inc. (Nasdaq: EMIS ) today announced ... of Vice President, Nonclinical Development and,Applied Biology, effective ... the oversight and management of nonclinical drug efficacy ... design of,discovery projects. Dr. Riley will report directly ...
Cached Biology Technology:New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties 2New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties 3New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties 4Consumers Call On Interstate Stem Cell Group To Endorse Open Meetings 2Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology 2Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology 3Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology 4
(Date:8/28/2014)... free mobile app called TX Invasives is now available ... University of Texas at Austin for identifying harmful non-native ... Invasive species in the United States cause about $137 ... destroy agricultural crops, clog waterways, kill native plants and ... Invasives app for reporting where invasive species occur, we,re ...
(Date:8/28/2014)... identified a handful of bacterial culprits that may drive ... ulcerative colitis, using patients, own intestinal immune responses as ... in the journal Cell . , Trillions of ... a critical role in the development and progression of ... of bacterial species affect a person,s susceptibility to IBD ...
(Date:8/28/2014)... German . ... to a striking pattern of blue stripes alternating with golden ... cells, and yellow cells emerge during growth in the skin ... mosaic to compose the characteristic colour pattern. ,While ... interact to form proper stripes, the embryonic origin of the ...
Breaking Biology News(10 mins):Mobile app makes ID of harmful plants, insects in Texas a snap 2Yale study identifies possible bacterial drivers of IBD 2How the zebrafish gets its stripes 2How the zebrafish gets its stripes 3
... 2011An essential question confronting neuroscientists and computer vision researchers alike ... image. Introspectively, we know that the human brain solves ... at something to know what it is. But teaching ... harder. In research published this fall in the Public Library ...
... 2011 New Report Added in ... Agreements . The Bioinformatics Partnering Terms ... to the bioinformatics partnering deals and agreements entered into ... provides a detailed understanding and analysis of how and ...
... recent years that wild chilies develop their trademark pungency, or heat, ... But that doesn,t explain why some chilies are hot and others ... in dry areas need more water to produce as many seeds ... threat in dryer environments so chilies in those areas are less ...
Cached Biology News:Do you see what I see? 2Do you see what I see? 3ResearchMoz: Bioinformatics Partnering Terms and Agreements 2ResearchMoz: Bioinformatics Partnering Terms and Agreements 3ResearchMoz: Bioinformatics Partnering Terms and Agreements 4ResearchMoz: Bioinformatics Partnering Terms and Agreements 5ResearchMoz: Bioinformatics Partnering Terms and Agreements 6To turn up the heat in chilies, just add water 2
96 Well Plate UB, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
... Forma Incubated Console Orbital Shakers combine ... ergonomics, unequalled programming power. The ... allowing the unit to run with ... HEPA filtration system reduces contamination. ...
...
... Shakers combine high durability and capacity ... of use. The patented triple-counterbalanced heavy-duty ... to run at high speed with ... temperature range is delivered with tight ...
Biology Products: